The LC–MS-based metabolomics of hydroxytyrosol administration in rats reveals amelioration of the metabolic syndrome

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 1041-1042, Issue , 2017, Pages 45-59

  Lemonakis, Nikolaos ^a   Poudyal, Hemant ^b,c   Halabalaki, Maria ^a   Brown, Lindsay ^b   Tsarbopoulos, Anthony ^d   Skaltsounis, Alexios Leandros ^a   Gikas, Evagelos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^c KYOTO UNIVERSITY   (Japan)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Hydroxytyrosol; Metabolic pathway analysis; Metabolic syndrome; Metabolomics

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; CARBOHYDRATES; LINOLEIC ACID; LIVER; METABOLISM; OLIVE OIL; PHYSIOLOGY; RATS; UNSATURATED FATTY ACIDS;

CHRONIC TREATMENT; FATTY ACID BIOSYNTHESIS; HYDROXYTYROSOL; METABOLIC CHANGES; METABOLIC PATHWAY ANALYSIS; METABOLIC SYNDROMES; METABOLOMICS; PLAUSIBLE MECHANISMS;

FATTY ACIDS;

ARACHIDONIC ACID; GLYCEROLIPID; HYDROXYTYROSOL; LINOLEIC ACID; RETINOL; SPHINGOLIPID; UNSATURATED FATTY ACID; 3,4-DIHYDROXYPHENYLETHANOL; PHENETHYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; FATTY ACID SYNTHESIS; LIPID DIET; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; LONG TERM CARE; MALE; METABOLIC SYNDROME X; METABOLITE; METABOLOME; METABOLOMICS; NONHUMAN; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; RAT; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; OLIVE TREE; PRINCIPAL COMPONENT ANALYSIS; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; MALE; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; OLEA; PHENYLETHYL ALCOHOL; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, WISTAR;

EID: 85006944671     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2016.12.020     Document Type: Article

References (44)

1. [1] Gami, A.S., Witt, B.J., Howard, D.E., Erwin, P.J., Gami, L., Somers, V.K., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J. Am. Coll. Cardiol. 49 (2007), 403–414.
2. [2] Ford, E.S., Li, C., Sattar, N., Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31 (2008), 1898–1904.
3. [3] Alberti, K.G.M.M., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 120 (2009), 1640–1645.
4. [4] Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Curr. Opin. Cardiol. 21 (2006), 1–6.
5. [5] Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M.R., Heymsfield, S.B., The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey. Arch. Intern. Med., 163, 2003, 427.
6. [6] Brown, L., Poudyal, H., Panchal, S.K., Functional foods as potential therapeutic options for metabolic syndrome. Obes. Rev. 16 (2015), 914–941.
7. [7] Covas, M.-I., de la Torre, R., Fitó, M., Virgin olive oil: a key food for cardiovascular risk protection. Br. J. Nutr. 113 (2015), S19–S28.
8. [8] Barbaro, B., Toietta, G., Maggio, R., Arciello, M., Tarocchi, M., Galli, A., et al. Effects of the olive-derived polyphenol oleuropein on human health. Int. J. Mol. Sci. 15 (2014), 18508–18524.
9. [9] López-Miranda, J., Pérez-Jiménez, F., Ros, E., De Caterina, R., Badimón, L., Covas, M.I., et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr. Metab. Cardiovasc. Dis. 20 (2010), 284–294.
10. [10] Keys, A., Menotti, A., Karvonen, M.J., Aravanis, C., Blackburn, H., Buzina, R., et al. The diet and 15-year death rate in the seven countries study. Am. J. Epidemiol. 124 (1986), 903–915.
11. [11] Babio, N., Bulló, M., Salas-Salvadó, J., Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr. 12 (2009), 1607–1617.
12. [12] Panagiotakos, D.B., Pitsavos, C., Polychronopoulos, E., Chrysohoou, C., Zampelas, A., Trichopoulou, A., Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. Med. Sci. Monit. 10 (2004), RA193–RA198.
13. [13] Poudyal, H., Campbell, F., Brown, L., Olive leaf extract attenuates cardiac hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J. Nutr. 140 (2010), 946–953.
14. [14] Visioli, F., Bernardini, E., Extra virgin olive oil's polyphenols: biological activities. Curr. Pharm. Des. 17 (2011), 786–804.
15. [15] Pérez-Jiménez, F., Ruano, J., Perez-Martinez, P., Lopez-Segura, F., Lopez-Miranda, J., The influence of olive oil on human health: not a question of fat alone. Mol. Nutr. Food Res. 51 (2007), 1199–1208.
16. [16] Mastralexi, A., Nenadis, N., Tsimidou, M.Z., Addressing analytical requirements to support health claims on olive oil polyphenols (EC regulation 432/2012). J. Agric. Food Chem. 62 (2014), 2459–2461.
17. [17] Cicerale, S., Conlan, X.A., Sinclair, A.J., Keast, R.S.J., Chemistry and health of olive oil phenolics. Crit. Rev. Food Sci. Nutr. 49 (2009), 218–236.
18. [18] Rafehi, H., Ververis, K., Karagiannis, T.C., Mechanisms of action of phenolic compounds in olive. J. Diet. Suppl. 9 (2012), 96–109.
19. [19] Vázquez-Velasco, M., Esperanza Díaz, L., Lucas, R., Gómez-Martínez, S., Bastida, S., Marcos, A., et al. Effects of hydroxytyrosol-enriched sunflower oil consumption on CVD risk factors. Br. J. Nutr. 105 (2011), 1448–1452.
20. [20] European Community. Council Regulation No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children's development and health, Off. J. Eur. Comm. (2012) L 136, 1–40.
21. [21] Efentakis, P., Iliodromitis, E.K., Mikros, E., Papachristodoulou, A., Dagres, N., Skaltsounis, A.-L., et al. Effects of the olive tree leaf constituents on myocardial oxidative damage and atherosclerosis. Planta Med. 81 (2015), 648–654.
22. [22] Andreadou, I., Benaki, D., Efentakis, P., Bibli, S.-I., Milioni, A.-I., Papachristodoulou, A., et al. The natural olive constituent oleuropein induces nutritional cardioprotection in normal and cholesterol-fed rabbits: comparison with preconditioning. Planta Med. 81 (2014), 655–663.
23. [23] Jemai, H., El Feki, A., Sayadi, S., Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J. Agric. Food Chem. 57 (2009), 8798–8804.
24. [24] Ristagno, G., Fumagalli, F., Porretta-Serapiglia, C., Orrù, A., Cassina, C., Pesaresi, M., et al. Hydroxytyrosol attenuates peripheral neuropathy in streptozotocin-induced diabetes in rats. J. Agric. Food Chem. 60 (2012), 5859–5865.
25. [25] H. Poudyal, N. Lemonakis, E. Gikas, M. Halabalaki, L. Skaltsounis, L. Brown, Hydroxytyrosol ameliorates metabolic, cardiovascular and liver changes in a rat model of diet-induced metabolic syndrome. Pharmacol. Metabolism-based Investig., Submitted for publication (n.d.).
26. [26] Wang, X., Lv, H., Zhang, A., Sun, W., Liu, L., Wang, P., et al. Metabolite profiling and pathway analysis of acute hepatitis rats by UPLC-ESI MS combined with pattern recognition methods. Liver Int., 2013.
27. [27] Snyder, N.W., Khezam, M., Mesaros, C.A., Worth, A., Blair, I.A., Untargeted metabolomics from biological sources using ultraperformance liquid chromatography-high resolution mass spectrometry (UPLC-HRMS). J. Vis. Exp., 2013, e50433.
28. [28] Xynos, N., Abatis, D., Argyropoulou, A., Polychronopoulos, P., Aligiannis, N., Skaltsounis, A.-L., Development of a sustainable procedure for the recovery of hydroxytyrosol from table olive processing wastewater using adsorption resin technology and centrifugal partition chromatography. Planta Med. 81 (2015), 1621–1627.
29. [29] Dunn, W., Broadhurst, D., Begley, P., Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6 (2011), 1060–1083.
30. [30] Xia, J., Wishart, D.S., Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6 (2011), 743–760.
31. [31] Xia, J., Mandal, R., Sinelnikov, I.V., Broadhurst, D., Wishart, D.S., MetaboAnalyst 2. 0-a comprehensive server for metabolomic data analysis. Nucl. Acids Res. 40 (2012), W127–W133.
32. [32] Xia, J., Psychogios, N., Young, N., Wishart, D.S., MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucl. Acids Res. 37 (2009), W652–60.
33. [33] Xia, J., Wishart, D.S., MetPA: a web-based metabolomics tool for pathway analysis and visualization. Bioinformatics 26 (2010), 2342–2344.
34. [34] Xia, J., Wishart, D.S., Metabolomic data processing, analysis, and interpretation using MetaboAnalyst. Curr. Protoc. Bioinform., 2011 (Chapter 14, Unit 14.10).
35. [35] van den Berg, R.A., Hoefsloot, H.C.J., Westerhuis, J.A., Smilde, A.K., van der Werf, M.J., Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genom., 7, 2006, 142.
36. [36] Westerhuis, J.A., Hoefsloot, H.C.J., Smit, S., Vis, D.J., Smilde, A.K., van Velzen, E.J.J., et al. Assessment of PLSDA cross validation. Metabolomics 4 (2008), 81–89.
37. [37] Larsson, O., Wahlestedt, C., Timmons, J.A., Considerations when using the significance analysis of microarrays (SAM) algorithm. BMC Bioinform., 6, 2005, 129.
38. [38] Cabrerizo, S., De La Cruz, J.P., López-Villodres, J.A., Muñoz-Marín, J., Guerrero, A., Reyes, J.J., et al. Role of the inhibition of oxidative stress and inflammatory mediators in the neuroprotective effects of hydroxytyrosol in rat brain slices subjected to hypoxia reoxygenation. J. Nutr. Biochem. 24 (2013), 2152–2157.
39. [39] Rhee, E.-J., Plutzky, J., Retinoid metabolism and diabetes mellitus. Diabetes Metab. J. 36 (2012), 167–180.
40. [40] Brozinick, J.T., Hawkins, E., Hoang Bui, H., Kuo, M.-S., Tan, B., Kievit, P., et al. Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet. Int. J. Obes. (Lond.) 37 (2013), 1064–1070.
41. [41] Yuyama, K., Mitsutake, S., Igarashi, Y., Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer's disease. Biochim. Biophys. Acta—Mol. Cell Biol. Lipids 1841 (2014), 793–798.
42. [42] Berg, J.M., Tymoczko, J.L., Stryer, L., Triacylglycerols Are Highly Concentrated Energy Stores. 2002, W H Freeman.
43. [43] Santos-Buelga, C., Andres-Lacueva, C., Scoditti, E., Calabriso, N., Massaro, M., Pellegrino, M., et al. Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch. Biochem. Biophys. 527 (2012), 81–89.
44. [44] Cao, K., Xu, J., Zou, X., Li, Y., Chen, C., Zheng, A., Li, H., Li, H., Szeto, I.M., Shi, Y., Long, J., Liu, J., Feng, Z., Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice. Free Radic. Biol. Med. 67 (2014), 396–407.